Table 6.

Multivariate analysis of entotic-CIC in PDAC and patient.

Factor		P value	Hazard ratio (95% CI)
Entotic-CIC	(Present vs. absent)	0.014	1.527 (1.090–2.138)
Gender	(Male vs. female)	0.005	1.431 (1.115–1.836)
Location	(Primary vs. metastasis)	<0.001	0.360 (0–0.474)
TP53	(Mutated vs. WT)	0.328	1.153 (0.866–1.535)
CDKN2A	(Mutated vs. WT)	0.217	1.197 (0.900–1.592)
APC	(Mutated vs. WT)	0.409	1.184 (0.792–1.771)
KRAS	(Amplified vs. not amplified)	0.020	2.742 (1.173–6.408)
FGFR1	(Amplified vs. not amplified)	0.944	0.959 (0.295–3.119)
CDKN2A	(Deep deletion vs. no deletion)	0.245	1.382 (0.801–2.386)